Aflac Incorporated(AFL)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Latest News & Analysis
Aflac (AFL): Q1 2025 Earnings, Ethical Standing, and Market Impact
Aflac's Q1 2025 earnings, ethical recognition, technology adoption, and dividend policy significantly influence its market performance. Investors should monitor these aspects closely.
Aflac's Growth Strategy: Ethics, Expansion, and Dividends
Aflac's strategic moves, ethical commitment, and financial health are under scrutiny. Dive into our data-driven analysis of AFL's recent performance and future prospects.
Aflac (AFL): Ethical Leadership, Strategic Growth, and Dividend Resilience
Aflac's ethical stance, strategic moves in dental/vision, and commitment to dividends drive resilience amidst economic shifts. A deep dive into AFL's prospects.
Aflac Incorporated: Industry Impact and Market Trends Analysis
Aflac Incorporated navigates market dynamics with strategic initiatives in dental, vision, and accident policies, alongside a focus on US growth and partnerships.
Aflac (AFL): Navigating Challenges and Expanding Supplemental Insurance Reach
Aflac faces challenges in Japan but expands in the US with new products and strategic partnerships. Dividend aristocrat status remains a key attraction for investors.
Aflac Analysis: Q4 Earnings, New Products, and Strategic Outlook
Aflac's Q4 earnings were a mixed bag, but new products and strategic partnerships offer promise. Fradkin's hire signals focus on dental/vision growth.
Aflac's Latest Performance: Q4 Earnings, Japan Challenges, and Future Outlook
Aflac's Q4 earnings missed estimates due to Japan market challenges, but U.S. expansion and dividend increases offer growth potential. Strategic partnerships are key.
Aflac (AFL) Analysis: Earnings, Dividends, and Strategic Outlook
Aflac's strategic moves, earnings, and dividend sustainability are analyzed, highlighting market challenges and growth opportunities. Partnership with the American Cancer Society emphasized.
Aflac: Navigating Challenges and Opportunities
Aflac faces mixed results in Q4 2024 with an earnings miss offset by strong revenue. A dividend increase signals financial health, while a new accident insurance policy aims to capture market share.
Aflac's Q4 2024 Performance: Navigating Japan and U.S. Growth
Aflac’s latest update reveals strong revenue gains amid Japanese market headwinds and robust U.S. growth, with a 16% dividend increase signaling confidence.
Aflac Q4 2024 Earnings: Navigating Challenges, US Growth
Aflac's Q4 earnings reveal Japan market challenges, offset by U.S. growth and a dividend boost, shaping its strategic path. All data from Monexa AI.